Search filters

List of works by Andrew Wei

Effectiveness of a single fixed dose of rasburicase 3 mg in the management of tumour lysis syndrome ⬇️

scientific article published on February 1, 2013

Fitness for intensive chemotherapy: a continuing conundrum

scientific article published in 2021

High‐dose cytarabine (24 g/m2) in combination with idarubicin (HiDAC‐3) results in high first‐cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia ⬇️

scientific article published on March 1, 2013

In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas

scholarly article

Limitations of targeted therapy with sorafenib in elderly high-risk myelodysplastic syndrome and acute myeloid leukemia ⬇️

scientific article published on 04 October 2012

MDM2 inhibition: an important step forward in cancer therapy

scientific article published on 10 July 2020

Maintenance therapy for AML: are we there yet?

scientific article published on 01 March 2019

Methylation of KLF5 contributes to reduced expression in acute myeloid leukaemia and is associated with poor overall survival ⬇️

scientific article published on March 25, 2013

Midostaurin, enasidenib, CPX-351, gemtuzumab ozogamicin, and venetoclax bring new hope to AML.

scientific article published on 19 October 2017

Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia.

scientific article published on 8 June 2017

Salvaging AML with CLAG: Novel option, or more of the same? ⬇️

scientific article published on November 11, 2010

The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.

scientific article published on November 2006

The epigenomics revolution in myelodysplasia: a clinico-pathological perspective ⬇️

scientific article published on October 1, 2011

Paulina is supported by:

About Paulina

Help